Significant fibrosis, as measured by FibroScan, was independently linked to type 2 diabetes in patients with metabolic dysfunction-associated steatotic liver disease. Medscape Medical News
Significant fibrosis, as measured by FibroScan, was independently linked to type 2 diabetes in patients with metabolic dysfunction-associated steatotic liver disease. Medscape Medical News